| scholarly article | Q13442814 |
| P2093 | author name string | Mario Monshouwer | |
| Xingrong Liu | |||
| Helen Yeo | |||
| Kristine Van Natta | |||
| Olga Vilenski | |||
| Paul E Weller | |||
| Philip D Worboys | |||
| P433 | issue | 4 | |
| P304 | page(s) | 787-793 | |
| P577 | publication date | 2008-12-30 | |
| P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
| P1476 | title | Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid | |
| P478 | volume | 37 |
| Q42905649 | 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'. |
| Q35183619 | A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder |
| Q28543817 | A predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systems |
| Q57684720 | ADME |
| Q40207908 | An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions |
| Q49485744 | Antibiotic diffusion to central nervous system |
| Q91718128 | Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats |
| Q37681555 | Assessing brain free fraction in early drug discovery |
| Q39454820 | Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations |
| Q57176317 | Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine |
| Q36136128 | Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma |
| Q90752502 | Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy |
| Q33744829 | Brain Tissue Binding of Drugs: Evaluation and Validation of Solid Supported Porcine Brain Membrane Vesicles (TRANSIL) as a Novel High-Throughput Method |
| Q50954690 | Calmodulin-like skin protein is downregulated in human cerebrospinal fluids of Alzheimer's disease patients with apolipoprotein E4; a pilot study using postmortem samples. |
| Q37667680 | Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury |
| Q30651426 | Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier |
| Q47371115 | Concentrations of cefuroxime in brain tissue of neurointensive care patients. |
| Q52141599 | Determination of the unbound fraction of R- and S-methadone in human brain. |
| Q36806807 | Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. |
| Q47668140 | Distribution of lacosamide in the rat brain assessed by in vitro slice technique |
| Q37538717 | Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation |
| Q35195516 | Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers |
| Q91194746 | Evaluation of Fraction Unbound Across 7 Tissues of 5 Species |
| Q37942267 | Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration |
| Q64105354 | Heterogeneous drug tissue binding in brain regions of rats, Alzheimer's patients and controls: impact on translational drug development |
| Q28283494 | History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia |
| Q36394062 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. |
| Q44128354 | In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study |
| Q35385971 | Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs |
| Q87431490 | Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery |
| Q92493555 | Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics |
| Q52646460 | Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration. |
| Q48501407 | Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs |
| Q39639495 | Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. |
| Q34142328 | Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections |
| Q42185986 | Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. |
| Q38247035 | Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system |
| Q37207750 | Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach |
| Q92009238 | Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants |
| Q41891370 | Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically |
| Q37265786 | Prediction of Drug Penetration in Tuberculosis Lesions |
| Q90439399 | Quantitative Intracerebral Microdialysis Studies to Determine Unbound Extracellular Fluid Drug Concentrations in Discrete Areas of the Brain |
| Q48651489 | Quantitative projection of human brain penetration of the H3 antagonist PF-03654746 by integrating rat-derived brain partitioning and PET receptor occupancy |
| Q41212866 | Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β. |
| Q89450421 | The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data |
| Q26850858 | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake |
| Q43069428 | The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid. |
| Q36697929 | The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects |
| Q48110851 | The use of microdialysis techniques in mice to study P-gp function at the blood-brain barrier |
| Q46616509 | Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor Occupancy |
| Q33882182 | Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke. |
| Q38080762 | Utility of CSF in translational neuroscience. |
| Q35973401 | Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging |
| Q48484054 | Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats |
| Q90751077 | Weak correlations between serum and cerebrospinal fluid levels of estradiol, progesterone and testosterone in males |
Search more.